Rotavirus is a virus that inflames the stomach and intestines. Its main side effects are diarrhea, vomiting, fever, and abdominal pain. In children, it can lead to severe dehydration, and if left untreated, death. Before a vaccine was regularly administered to children starting in 2006, rotavirus was the cause of many hospital and emergency room visits.

Globally, rotavirus is responsible for about half a million deaths in children under the age of five. In areas without good sanitation, healthcare, and health education, the spread of such diseases and the lack of treatment are likely the reason the virus is still claiming so many young lives.

In India, rotavirus claims 100,000 lives every year. India’s Department of Biotechnology and the company Bharat Biotech have developed a new vaccine called RotaVac that effectively prevents the diarrhea, one of the strongest symptoms of rotavirus. If administered to children all over India, especially to those from low-to no-income families, it would prevent a viral infection that would otherwise have devastating results.

The group of researchers who developed the vaccine consisted of scientists from all over the world. Phase III of the clinical trial took place in three different locations in India. Not only did it prove effective, but Bharat Biotech has priced the vaccine at $1 USD, which is relatively affordable.

Along with the usual vaccines, it would be administered at 6, 10, and 14 weeks of age. Awareness and taking preventive steps are two very effective ways to combat diseases such as this, especially in areas with lackluster healthcare.

– Aalekhya Malladi

Sources: Defeat DD, CDV
Photo: GAVI Alliance